These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2070817)
1. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes. Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817 [TBL] [Abstract][Full Text] [Related]
2. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Uehara Y; Fukazawa H; Murakami Y; Mizuno S Biochem Biophys Res Commun; 1989 Sep; 163(2):803-9. PubMed ID: 2783121 [TBL] [Abstract][Full Text] [Related]
4. Effects of herbimycin A and various SH-reagents on p60v-src kinase activity in vitro. Fukazawa H; Mizuno S; Uehara Y Biochem Biophys Res Commun; 1990 Nov; 173(1):276-82. PubMed ID: 2175179 [TBL] [Abstract][Full Text] [Related]
5. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase. Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356 [TBL] [Abstract][Full Text] [Related]
6. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Uehara Y; Fukazawa H Methods Enzymol; 1991; 201():370-9. PubMed ID: 1658554 [No Abstract] [Full Text] [Related]
7. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro. Fukazawa H; Li PM; Yamamoto C; Murakami Y; Mizuno S; Uehara Y Biochem Pharmacol; 1991 Oct; 42(9):1661-71. PubMed ID: 1656993 [TBL] [Abstract][Full Text] [Related]
8. Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells. Murakami Y; Mizuno S; Uehara Y Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):63-8. PubMed ID: 8037692 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A. Uehara Y; Murakami Y; Mizuno S; Kawai S Virology; 1988 May; 164(1):294-8. PubMed ID: 2452516 [TBL] [Abstract][Full Text] [Related]
10. Effect of herbimycin A on hsp30 and hsp70 heat shock protein gene expression in Xenopus cultured cells. Briant D; Ohan N; Heikkila JJ Biochem Cell Biol; 1997; 75(6):777-82. PubMed ID: 9599667 [TBL] [Abstract][Full Text] [Related]
11. Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression? Morris SD; Cumming DV; Latchman DS; Yellon DM J Clin Invest; 1996 Feb; 97(3):706-12. PubMed ID: 8609226 [TBL] [Abstract][Full Text] [Related]
12. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism. Fukazawa H; Uehara Y; Murakami Y; Mizuno S; Hamada M; Takeuchi T FEBS Lett; 1994 Mar; 340(3):155-8. PubMed ID: 8131836 [TBL] [Abstract][Full Text] [Related]
13. Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines. Sato S; Honma Y; Hozumi M; Hayashi Y; Matsuo Y; Shibata K; Omura S; Hino K; Tomoyasu S; Tsuruoka N Leuk Res; 1994 Mar; 18(3):221-8. PubMed ID: 8139288 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1. Uehara Y; Murakami Y; Sugimoto Y; Mizuno S Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877 [TBL] [Abstract][Full Text] [Related]
15. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS. Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216 [TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity of herbimycin A, a tyrosine kinase inhibitor, targeted against BCR/ABL oncoprotein in mice bearing BCR/ABL-transfected cells. Okabe M; Uehara Y; Noshima T; Itaya T; Kunieda Y; Kurosawa M Leuk Res; 1994 Nov; 18(11):867-73. PubMed ID: 7967714 [TBL] [Abstract][Full Text] [Related]
18. Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cells. Okabe M; Kawamura K; Miyagishima T; Itaya T; Goodwyn D; Shoji M; Vogler WR; Sakurada K; Uehara M; Miyazaki T Leuk Res; 1994 Mar; 18(3):213-20. PubMed ID: 7511193 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of ret tyrosine kinase activity by herbimycin A. Taniguchi M; Uehara Y; Matsuyama M; Takahashi M Biochem Biophys Res Commun; 1993 Aug; 195(1):208-14. PubMed ID: 8363602 [TBL] [Abstract][Full Text] [Related]
20. Effects of the protein tyrosine kinase inhibitor, herbimycin A, on prolactin gene expression in GH3 and 235-1 pituitary tumor cells. Billis WM; White BA Biochim Biophys Acta; 1997 Aug; 1358(1):31-8. PubMed ID: 9296518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]